AbbVie wins reversal of $140 million verdict in case over AndroGel risks

(Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack.

from Reuters: Health News https://ift.tt/2z9MQLE
via IFTTT